Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Troubadour 

Sangamo Bioscienes diskutieren

Sangamo Therapeutics Inc.

WKN: 936386 / Symbol: SGMO / Name: Sangamo Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,53 €
4,78 %

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SGMO provided by MarketBeat

Einschätzung Buy
Rendite (%) -31,11 %
Kursziel 2,76
Veränderung
Endet am 18.03.25

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.00 price target on the stock.
Ratings data for SGMO provided by MarketBeat

Einschätzung Buy
Rendite (%) -31,32 %
Kursziel 4,61
Veränderung
Endet am 19.03.25

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock, up previously from $3.00.
Ratings data for SGMO provided by MarketBeat

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SGMO provided by MarketBeat

Einschätzung Buy
Rendite (%) -1,90 %
Kursziel 4,60
Veränderung
Endet am 15.05.25

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $5.00 price target on the stock.
Ratings data for SGMO provided by MarketBeat